Horizon Therapeutics PLC (OQ:HZNP)

INK Ultra Money Free

INK Ultra Money Premium

Get a Canadian Insider Club Ultra subscription for

  • Insider filing email alerts
  • Access to premium INK Research reports
  • Full access to weekly North America Top filer reports
  • Ad-free browsing
  • INK Ultra Money premium content

(already an Ultra member? Please log into your account for access)

Latest 10 SEC filings (by transaction date) for HZNP within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 6/19 Dec 5/19 DesJardin Michael A. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -5,860  
Dec 6/19 Dec 5/19 DesJardin Michael A. Direct Ownership Ordinary Shares F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -2,906 $31.86
Dec 6/19 Dec 5/19 DesJardin Michael A. Direct Ownership Ordinary Shares M - Exercise or conversion exempt under rule 16b-3 5,860  
Nov 27/19 Nov 25/19 Beeler Brian K Direct Ownership Ordinary Shares S - Open market or private sale -5,000 $32.52
Nov 27/19 Nov 25/19 Beeler Brian K Direct Ownership Ordinary Shares S - Open market or private sale -4,969 $32.50
Nov 15/19 Nov 14/19 McHugh Miles W Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -4,516  
Nov 15/19 Nov 14/19 McHugh Miles W Direct Ownership Ordinary Shares M - Exercise or conversion exempt under rule 16b-3 4,516 $22.14
Nov 7/19 Nov 5/19 Beeler Brian K Direct Ownership Ordinary Shares S - Open market or private sale -8,775 $30.02
Nov 7/19 Nov 5/19 Beeler Brian K Direct Ownership Ordinary Shares S - Open market or private sale -3,700 $30.00
Nov 5/19 Nov 1/19 Pasternak Andy Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 37,262  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for HZNP within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 6/19 Dec 5/19 DesJardin Michael A. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -5,860  
Dec 6/19 Dec 5/19 DesJardin Michael A. Direct Ownership Ordinary Shares F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -2,906 $31.86
Dec 6/19 Dec 5/19 DesJardin Michael A. Direct Ownership Ordinary Shares M - Exercise or conversion exempt under rule 16b-3 5,860  
Nov 27/19 Nov 25/19 Beeler Brian K Direct Ownership Ordinary Shares S - Open market or private sale -5,000 $32.52
Nov 27/19 Nov 25/19 Beeler Brian K Direct Ownership Ordinary Shares S - Open market or private sale -4,969 $32.50
Nov 15/19 Nov 14/19 McHugh Miles W Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -4,516  
Nov 15/19 Nov 14/19 McHugh Miles W Direct Ownership Ordinary Shares M - Exercise or conversion exempt under rule 16b-3 4,516 $22.14
Nov 7/19 Nov 5/19 Beeler Brian K Direct Ownership Ordinary Shares S - Open market or private sale -8,775 $30.02
Nov 7/19 Nov 5/19 Beeler Brian K Direct Ownership Ordinary Shares S - Open market or private sale -3,700 $30.00
Nov 5/19 Nov 1/19 Pasternak Andy Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 37,262  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $HZNP

Competitors

Competitors with Recent Insider Filings
Odonate Therapeutics (OQ:ODT)
Merck & Co. (N:MRK)
Morphic Holding (OQ:MORF)